Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal Surgery
NCT ID: NCT00766519
Last Updated: 2013-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
104 participants
INTERVENTIONAL
2009-02-28
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Optimization
volume optimization: continuous monitoring of the respiratory-induced arterial pulse pressure variation during surgery and systematic minimization to 10% or less by volume loading
volume optimization
Fluid management:
* basal fluid administration = 5 ml/kg/h lactated Ringer's solution
\+ systematic minimization of the arterial pulse pressure variation (PPV) to 10% or less by volume loading (6% hydroxyethyl starch) throughout surgery
* hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) only if PPV is \> 10%
control; standard volume administration
standard volume administration
standard volume administration
Fluid management:
* basal fluid administration = 5 ml/kg/h lactated Ringer's solution
* hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) according to predetermined algorithm primarily based on mean arterial pressure, heart rate, and urine output, and secondary on PPV
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
volume optimization
Fluid management:
* basal fluid administration = 5 ml/kg/h lactated Ringer's solution
\+ systematic minimization of the arterial pulse pressure variation (PPV) to 10% or less by volume loading (6% hydroxyethyl starch) throughout surgery
* hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) only if PPV is \> 10%
standard volume administration
Fluid management:
* basal fluid administration = 5 ml/kg/h lactated Ringer's solution
* hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) according to predetermined algorithm primarily based on mean arterial pressure, heart rate, and urine output, and secondary on PPV
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hepatectomy
* associated thoracic surgery
* laparoscopy
* pregnancy
* allergy to colloid solution or anesthesia protocol
* arterial catheter not possible
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoit TAVERNIER, MD, PhD
Role: STUDY_DIRECTOR
University Hospital, Lille
Benoit VALLET, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Amiens, , France
University Hospital
Caen, , France
Département d'Anesthésie-Réanimation, Hôpital Estaing, CHU
Clermont-Ferrand, , France
University hospital Henri-Mondor
Créteil, , France
University Hospital
Lille, , France
University Hospital
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRC 2006/1915
Identifier Type: OTHER
Identifier Source: secondary_id
2007/0723
Identifier Type: OTHER
Identifier Source: secondary_id
2007-A01436-47
Identifier Type: -
Identifier Source: org_study_id